Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 2
1990 2
1991 8
1992 4
1993 4
1994 18
1995 20
1996 26
1997 35
1998 70
1999 68
2000 85
2001 133
2002 121
2003 170
2004 150
2005 189
2006 173
2007 213
2008 233
2009 280
2010 279
2011 298
2012 270
2013 265
2014 374
2015 367
2016 386
2017 403
2018 364
2019 393
2020 402
2021 413
2022 397
2023 380
2024 376
2025 357
2026 201

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,151 results

Results by year

Filters applied: . Clear all
Page 1
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, Ferencik M. Chou R, et al. JAMA. 2022 Aug 23;328(8):754-771. doi: 10.1001/jama.2022.12138. JAMA. 2022. PMID: 35997724
IMPORTANCE: A 2016 review for the US Preventive Services Task Force (USPSTF) found use of statins for primary prevention of cardiovascular disease (CVD) was associated with reduced mortality and cardiovascular outcomes. ...Otherwise, there were no clear diffe …
IMPORTANCE: A 2016 review for the US Preventive Services Task Force (USPSTF) found use of statins for primary prevention …
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB. US Preventive Services Task Force, et al. JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044. JAMA. 2022. PMID: 35997723 Review.
The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of statin use for the primary prevention of CVD events and mortality in adults 76 years or older with no history of CVD. ...(C recommendation) The USPSTF con …
The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of statin use for the primar …
Primary prevention statin therapy in older adults.
Nanna MG, Abdullah A, Mortensen MB, Navar AM. Nanna MG, et al. Curr Opin Cardiol. 2023 Jan 1;38(1):11-20. doi: 10.1097/HCO.0000000000001003. Epub 2022 Nov 2. Curr Opin Cardiol. 2023. PMID: 36598445 Free PMC article. Review.
Despite these data supporting their use, current guidelines conflict in their statin treatment recommendations in those aged 70-75 years. Reflecting the paucity of evidence, the same guidelines are equivocal around primary prevention statins in those b …
Despite these data supporting their use, current guidelines conflict in their statin treatment recommendations in those aged 70-75 ye …
Statin therapy in primary and secondary cardiovascular disease prevention.
Paparodis RD, Bantouna D, Livadas S, Angelopoulos N. Paparodis RD, et al. Curr Atheroscler Rep. 2024 Dec 30;27(1):21. doi: 10.1007/s11883-024-01265-9. Curr Atheroscler Rep. 2024. PMID: 39738779 Review.
Elevated low-density lipoprotein (LDL) cholesterol is one of the main modifiable disease risk factors and statin therapies have been extensively studied in that regard. The present work presents the clinical trials derived evidence supporting the use of statins in …
Elevated low-density lipoprotein (LDL) cholesterol is one of the main modifiable disease risk factors and statin therapies have been …
Statin therapy for the primary prevention of cardiovascular disease: Pros.
Razavi AC, Mehta A, Sperling LS. Razavi AC, et al. Atherosclerosis. 2022 Sep;356:41-45. doi: 10.1016/j.atherosclerosis.2022.07.004. Epub 2022 Jul 14. Atherosclerosis. 2022. PMID: 35945050 Review.
The initiation of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) remains a debated subject, despite decades worth of clinical trial data demonstrating efficacy, effectiveness, and safety. ...Thus, the era of precision med …
The initiation of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) remains a debate …
Statin Therapy for Primary and Secondary Prevention in Older Adults.
Bao A, Karalis DG. Bao A, et al. Curr Atheroscler Rep. 2024 Nov 25;27(1):11. doi: 10.1007/s11883-024-01257-9. Curr Atheroscler Rep. 2024. PMID: 39585440 Free PMC article. Review.
PURPOSE OF REVIEW: Although statin therapy is well established to prevent atherosclerotic vascular disease (ASCVD) events in adults 40 to 75 years of age, it is less clear whether older adults benefit from statin therapy. The purpose of this review is to summarize t …
PURPOSE OF REVIEW: Although statin therapy is well established to prevent atherosclerotic vascular disease (ASCVD) events in adults 4 …
Statin therapy for the primary prevention of cardiovascular disease: Cons.
Durai V, Redberg RF. Durai V, et al. Atherosclerosis. 2022 Sep;356:46-49. doi: 10.1016/j.atherosclerosis.2022.07.003. Epub 2022 Jul 20. Atherosclerosis. 2022. PMID: 35934533 Review.
When healthy patients without cardiovascular disease are prescribed statins they do not live longer, and they have only a marginal reduction in the risk of ischemic events. Furthermore, statins cause numerous side effects which substantially limit their net benefit. …
When healthy patients without cardiovascular disease are prescribed statins they do not live longer, and they have only a marginal re …
Statin therapy for primary prevention in men: What is the role for coronary artery calcium?
Grundy SM, Wang J, Vega GL. Grundy SM, et al. J Clin Lipidol. 2023 Jan-Feb;17(1):12-18. doi: 10.1016/j.jacl.2022.11.001. Epub 2022 Nov 24. J Clin Lipidol. 2023. PMID: 36593174
Current cholesterol guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) base statin treatment decisions on multiple risk factor algorithms (e.g., Pooled Cohort Equations [PCEs]). By available PCEs, most older middle-aged men ar …
Current cholesterol guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) base statin tre …
Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients.
Strandberg TE. Strandberg TE. Curr Atheroscler Rep. 2019 May 20;21(8):28. doi: 10.1007/s11883-019-0793-7. Curr Atheroscler Rep. 2019. PMID: 31111235 Free PMC article. Review.
After 75 years, treatment should be started in patients with ASCVD and judiciously in primary prevention. Like all prevention, statin treatment should be discontinued when palliative treatment is started. Ongoing and planned trials in 70+ individuals w …
After 75 years, treatment should be started in patients with ASCVD and judiciously in primary prevention. Like all preventi …
Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
Rochlani Y, Kattoor AJ, Pothineni NV, Palagiri RDR, Romeo F, Mehta JL. Rochlani Y, et al. Am J Cardiol. 2017 Oct 1;120(7):1122-1128. doi: 10.1016/j.amjcard.2017.06.054. Epub 2017 Jul 14. Am J Cardiol. 2017. PMID: 28797470 Review.
Currently, the US Preventive Services Task Force recommend the use of statins for primary prevention in patients with at least 1 cardiovascular risk factor and a 10-year risk of >7.5%. ...This article aims to highlight the existing data on statin us …
Currently, the US Preventive Services Task Force recommend the use of statins for primary prevention in patients with a …
7,151 results